Drug intelligence / Profile preview

diclofenac + menthol + methyl salicylate

Development stage
Approved
Lead developer
V2 Pharma
Modality
Small Molecules
Administration
Topical
01

Overview

This is a **topical analgesic combination** containing diclofenac (a nonsteroidal anti-inflammatory drug, NSAID), menthol (a counterirritant), and methyl salicylate (a counterirritant and salicylate). Diclofenac reduces pain and inflammation by inhibiting cyclooxygenase (COX) enzymes, lowering prostaglandin synthesis. Menthol and methyl salicylate provide rapid cooling and warming sensations, primarily distracting from pain via counterirritant effects and by interfering with pain signal transmission at the skin and superficial nerves. Methyl salicylate is also metabolized locally to salicylic acid, contributing further anti-inflammatory properties. The combination is mainly used for temporary relief of minor aches and pains of muscles and joints, e.g., arthritis, simple backache, strains, sprains, and bruises. It is available as a cream, gel, spray, or patch for adults and children over 12 years[1][4][5].

Brand names
VarophenFenovar
Other names
diclofenac-methyl salicylate-menthol topical
02

Targets

TRPA1 (Transient receptor potential cation channel subfamily A member 1)TRPV1 (Transient receptor potential cation channel subfamily V member 1)PGHS-1 (Prostaglandin G/H Synthase 1)

Beyond the preview

Go deeper on diclofenac + menthol + methyl salicylate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on diclofenac + menthol + methyl salicylate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call